GOWER, Brad L.,PARK, Jae Han,HERMAN, Clifford J.,LAI, Tsz Chung,FENG, Kai
申请号：
EP17750563
公开号：
EP3413893A4
申请日:
2017.01.27
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition provides extended release of the API and has abuse deterrent features.
